Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D3 24-hydroxylase mRNA expression in the skin of calcipotriol-treated psoriatic patients correlates with clinical efficacy

  • Short Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–C

References

  1. Reichrath J, Perez A, Müller M, Chen TC, Kerber A, Bahmer FA, Holick MF (1997) Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation. Acta Derm Venereol 77:268–272

    CAS  PubMed  Google Scholar 

  2. Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D. Physiol Rev 78:1193–1231

    CAS  PubMed  Google Scholar 

  3. Kragballe K (1995) Calcipotriol: a new drug for topical psoriasis treatment. Pharmacol Toxicol 77:241–246

    CAS  PubMed  Google Scholar 

  4. Majewski S, Kutner A, Jablonska S (2000) Vitamin D analogues in cutaneous malignancies. Curr Pharm Des 6:829–838

    CAS  PubMed  Google Scholar 

  5. Uskokovic MR, Norman AW, Manchand PS, Studzinski GP, Campbell MJ, Koeffler HP, Takeuchi A, Siu-Caldera ML, Rao DS, Reddy GS (2001) Highly active analogs of 1alpha,25-dihydroxyvitamin D(3) that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids 66:463–471

    Article  CAS  PubMed  Google Scholar 

  6. Reddy GS, Tserng KY (1989) Calcitroic acid, end product of renal metabolism of 1,25-dihydroxyvitamin D3 through C-24 oxidation pathway. Biochemistry 28:1763–1769

    CAS  PubMed  Google Scholar 

  7. Chen ML, Heinrich G, Holick MF (1994) Expression of 25-hydroxyvitamin D3-24-hydroxylase mRNA in cultured human keratinocytes. Proc Soc Exp Biol Med 207:57–61

    CAS  PubMed  Google Scholar 

  8. Masuda S, Strugnell T, Calverly MJ, Makin HLJ, Kremer R, Jones G (1994) In vitro metabolism of the anti-psoriatic vitamin D analog, calcipotriol, in two cultured human keratinocyte models. J Biol Chem 269:4794–4803

    CAS  PubMed  Google Scholar 

  9. De Brugerolle de Fraissinette, Picarles V, Chibout S, Kolopp M, Medina J, Burtin P, Ebelin ME, Osborne S, Mayer FK, Spake A, Rosdy M, De Wever B, Ettlin RA, Cordier A (1999) Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles. Cell Biol Toxicol 15:121–135

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Preclinical Safety Department, Novartis Pharma AG, CH-4002, Basel, Switzerland

    Salah-Dine Chibout, Anne de Brugerolle de Fraissinette, Nicole Hartmann, Valerie Picarles, Olivier Grenet, André Cordier & Jesús Medina

  2. Clinical Research Department, Novartis Pharma AG, CH-4002, Basel, Switzerland

    Stephen Molloy

Authors
  1. Salah-Dine Chibout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne de Brugerolle de Fraissinette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicole Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Valerie Picarles
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olivier Grenet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. André Cordier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Stephen Molloy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jesús Medina
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salah-Dine Chibout.

Additional information

Financial support for this study was provided by Novartis Pharma AG, Basel, Switzerland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chibout, SD., de Brugerolle de Fraissinette, A., Hartmann, N. et al. Vitamin D3 24-hydroxylase mRNA expression in the skin of calcipotriol-treated psoriatic patients correlates with clinical efficacy. Arch Dermatol Res 295, 269–271 (2003). https://doi.org/10.1007/s00403-003-0428-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-003-0428-1

Keywords

Search

Navigation